US regulator approves pill form of Wegovy weight-loss drug

BBC News - WorldEN 1 min read 100% complete December 23, 2025 at 02:29 AM

AI Summary

short article 1 min

The US FDA has approved a pill form of Wegovy, a weight-loss drug made by Novo Nordisk, marking the first such approval for a weight-loss pill in the US. The once-daily pill is designed to provide the same weight loss as the injectable version, with trials showing an average weight loss of 16.6%. Novo Nordisk plans to launch the pill in the US in early January 2026, offering a more convenient option for patients. The approval could boost Novo Nordisk's sales amidst competition in the weight-loss market, and its shares rose following the announcement. While other drugs like Ozempic have weight-loss effects, Wegovy was specifically approved for weight loss.

Key Entities & Roles

Key Player Opposition Context

New York 30% Mike Doustdar 40% Eli Lilly 40% Ozempic 50% United States ×270% Wegovy ×680% United States Food and Drug Administration (FDA) ×385% Novo Nordisk ×790%

Keywords

weight-loss drug 100% wegovy 90% fda approval 80% novo nordisk 70% pill form 70% pharmaceutical 50% clinical trials 50% ozempic 40% market competition 40%